article thumbnail

As FDA puts CAR-T safety under microscope, researchers dig into adverse events record of BCMA therapies

Fierce Pharma

But these immunotherapies also come with various potentially dangerous side effects. | A new study examined side effect reports of BMCA immunotherapies from the FDA Adverse Event Reporting System, hoping to help inform doctors in their treatment decisions.

article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The biobank will work in parallel with the MHRA’s Yellow Card website, which is used for reporting adverse events and side effects caused by medicines and medical devices, per the 25 May announcement. According to the press release, the MHRA will be the first drug safety regulator in the world to pilot such a biobank.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medical Sales Strategies: How to Drive Doctors’ Recommendations

MaBiCo

Medical Sales Strategies: How to Drive Doctors’ Recommendations Medical sales are a set of activities and skills whose purpose is to influence health care professionals to recommend or prescribe a product. Selling to private practice doctors is different than selling to healthcare organizations.

article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

Today, people don’t see a DTC TV ad and run to their doctor to ask for an Rx. 3hree: DTC marketing minimizes the side effects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.” Still, the gatekeeper continues to be their doctor.

Marketing 285
article thumbnail

EMA approves biosimilar interchangeability in EU

European Pharmaceutical Review

This interchangeability refers to the fact that a reference medicine can be substituted by a biosimilar, without risk, side effects or outcomes different to the original drug. Clinically, it is common practice for doctors to rotate patients between different biologics.

article thumbnail

Is DTC effective?

World of DTC Marketing

The old belief is that patients who are interested in new treatments ask their doctor about them. What are the side effects? They’re going to go online where they can read the safety warnings that too often than not scare them because they lack context. What happens when someone is interested in a new DTC product?

article thumbnail

Healthcare Watch October 2023

PM360

Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. doctors are calling two particular drugs “paradigm-shifting”—tirzepatide, sold as Mounjaro , and semaglutide, sold as the brands Ozempic , Wegovy , and Rybelsus.